Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma

Introduction: Neoadjuvant therapy is increasingly being used for localized pancreatic adenocarcinoma. While there is evidence supporting neoadjuvant systemic chemotherapy as well as chemoradiation, more evidence is needed to determine whether systemic chemotherapy with chemoradiation offers benefits...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Trinh, Katherine V., Fischer, Dawn A., Gardner, Timothy B., Smith, Kerrington D.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7525017/
https://ncbi.nlm.nih.gov/pubmed/33042792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01461
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items